Shandong Xinhua Pharmaceutical Co (HKSE:00719) EBIT per Share : HK$0.88 (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Shandong Xinhua Pharmaceutical Co EBIT per Share?

Shandong Xinhua Pharmaceutical Co's EBIT per Share for the three months ended in Mar. 2024 was HK$0.29. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was HK$0.88.

During the past 12 months, the average EBIT per Share Growth Rate of Shandong Xinhua Pharmaceutical Co was -2.50% per year. During the past 3 years, the average EBIT per Share Growth Rate was 0.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was 3.60% per year. During the past 10 years, the average EBIT per Share Growth Rate was 21.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Shandong Xinhua Pharmaceutical Co's EBIT per Share or its related term are showing as below:

HKSE:00719' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -34.8 Med: 8 Max: 46
Current: 0.7

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Shandong Xinhua Pharmaceutical Co was 46.00% per year. The lowest was -34.80% per year. And the median was 8.00% per year.

HKSE:00719's 3-Year EBIT Growth Rate is ranked worse than
61.7% of 859 companies
in the Drug Manufacturers industry
Industry Median: 7.9 vs HKSE:00719: 0.70

Shandong Xinhua Pharmaceutical Co's EBIT for the three months ended in Mar. 2024 was HK$193 Mil.

Shandong Xinhua Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Shandong Xinhua Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Xinhua Pharmaceutical Co EBIT per Share Chart

Shandong Xinhua Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.78

0.89

0.93

0.86

0.91

Shandong Xinhua Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.33	0.25	0.20	0.15	0.29

Shandong Xinhua Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Shandong Xinhua Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	627.648	/	689.600
=	0.91

Shandong Xinhua Pharmaceutical Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	193.35	/	675.616
=	0.29

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.88

Shandong Xinhua Pharmaceutical Co (HKSE:00719) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Shandong Xinhua Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Shandong Xinhua Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Xinhua Pharmaceutical Co (HKSE:00719) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (HKSE:00719) » Definitions » EBIT per Share

Traded in Other Exchanges

XIN:Germany 000756:China

Address

No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo City, Shandong, CHN, 255086

Website

http://www.xhzy.com

Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.

Shandong Xinhua Pharmaceutical Co (HKSE:00719) Headlines

No Headlines